Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-09-30
1995-02-14
Henley, III, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
053896815
ABSTRACT:
The invention relates to a pharmaceutical composition in the form of a sterilizable parenteral solution comprising a diclofenac salt and stabilizers, such as ethyl lactate combined with glutathione or N-acetylcysteine.
REFERENCES:
patent: 4309421 (1982-01-01), Ghyczy et al.
patent: 4593044 (1986-06-01), Metz
patent: 4711906 (1987-12-01), von Stetten et al.
patent: 5079001 (1992-01-01), Affolter
A. F. Gunnison et al: Sulfite Hypersensitivity. A critical Review, CRC Critical Review in Toxicology, vol. 17 (1987), Issue 3, pp. 185-214.
Search Report, European Patent Application No. 93810720.8 Ciba-Geigy (1993).
Ciba-Geigy Corporation
Fishman Irving M.
Henley III Raymond J.
Kaiser Karen G.
LandOfFree
Parenteral solutions for diclofenac salts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Parenteral solutions for diclofenac salts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral solutions for diclofenac salts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-288635